Guidant CE-marks aortoiliac graft:
This article was originally published in Clinica
Guidant has gained the go-ahead to market in Europe its Ancure Aortoiliac Endograft device as a less invasive treatment for those patients with abdominal aortic aneurysms (AAA), who are ineligible for Guidant's current endovascular graft due to advanced vascular disease in the iliac arteries. The product comprises a polyester graft or tube that is inserted through an incision in the groin and attached to the aorta with tiny metal hooks. This reinforces the aorta wall. The Indianapolis, Indiana firm plans to introduce the latest product in its line of aortic grafting devices in the US this year, pending FDA approval.